HZ

Henrik Zetterberg

Clinical Neurochemistry Laboratory, University of Gothenburg

Affiliated withUniversity of GothenburgThe Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University HospitalSahlgrenska University Hospital

+4

Research Area

Biography

Henrik Zetterberg has not added Biography.
If you are Henrik Zetterberg and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 3
Year
A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Publication title

Cited by 3

2016
2017
2017

Other Publications

Article
Year
Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease.

Molecular neurodegeneration| PubMed ID: 20145736

2010
Association of APOE with age at onset of sporadic amyotrophic lateral sclerosis.

Journal of the neurological sciences| PubMed ID: 18656208

2008
2009
Synaptic retrogenesis and amyloid-beta in Alzheimer's disease.

Journal of Alzheimer's disease : JAD| PubMed ID: 19158416

2009
2009
2009
2009
2009
2009
Amyloid beta and APP as biomarkers for Alzheimer's disease.

Experimental gerontology| PubMed ID: 19698775

2010
2010
2010
Subcortical vascular dementia biomarker pattern in mild cognitive impairment.

Dementia and geriatric cognitive disorders| PubMed ID: 19864909

2009
CSF biomarkers: pinpointing Alzheimer pathogenesis.

Annals of the New York Academy of Sciences| PubMed ID: 19906258

2009
2010
2010
2010
2010
2010
Biochemical markers in Alzheimer's disease clinical trials.

Biomarkers in medicine| PubMed ID: 20387305

2010
2010
2008
2010
2010
2010
Lessons from Multicenter Studies on CSF Biomarkers for Alzheimer's Disease.

International journal of Alzheimer's disease| PubMed ID: 20721354

2010
To know or not to know: ethical issues related to early diagnosis of Alzheimer's disease.

International journal of Alzheimer's disease| PubMed ID: 20798843

2010
Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid.

International journal of Alzheimer's disease| PubMed ID: 20798852

2010
2010
2010
2011
Cerebrospinal fluid analysis should be considered in patients with cognitive problems.

International journal of Alzheimer's disease| PubMed ID: 21487447

2010
Biomarker-based dissection of neurodegenerative diseases.

Progress in neurobiology| PubMed ID: 21524681

2011
2011
2011
Biomarkers for microglial activation in Alzheimer's disease.

International journal of Alzheimer's disease| PubMed ID: 22114747

2011
2011
2012
2012
2012
Cerebrospinal fluid biomarkers for Alzheimer's disease: more to come?

Journal of Alzheimer's disease : JAD| PubMed ID: 22710917

2013
2012
2012
2012
2012
Fluid biomarkers in Alzheimer disease.

Cold Spring Harbor perspectives in medicine| PubMed ID: 22951438

2012
Serum levels of LIGHT in MS.

Multiple sclerosis (Houndmills, Basingstoke, England)| PubMed ID: 23037546

2013
2012
2013
2013
2014
2013
2013
2014
2013
2014
2014
2014
2016
2014
The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?

Alzheimer's & dementia : the journal of the Alzheimer's Association| PubMed ID: 24721526

2014
2014
2014
2014
2014
2015
2015
2014
2014
2015
2015
Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association| PubMed ID: 25533203

2015
2014
2015
2014
2015
2015
Laboratory testing for lyme neuroborreliosis.

JAMA neurology| PubMed ID: 25581864

2015
2015
2015
2015
Explorative and targeted neuroproteomics in Alzheimer's disease.

Biochimica et biophysica acta| PubMed ID: 25619854

2015
2016
2015
Repetitive concussions--How dangerous are they?

Molecular and cellular neurosciences| PubMed ID: 25655012

2015
Fluid markers of traumatic brain injury.

Molecular and cellular neurosciences| PubMed ID: 25659491

2015
Genetic Variants and Related Biomarkers in Sporadic Alzheimer's Disease.

Current genetic medicine reports| PubMed ID: 25664224

2015
Alzheimer's disease--Recent biomarker developments in relation to updated diagnostic criteria.

Clinica chimica acta; international journal of clinical chemistry| PubMed ID: 25668231

2015
2015
2015
Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)| PubMed ID: 25732842

2015
2015
Monocyte and microglial activation in patients with mood-stabilized bipolar disorder.

Journal of psychiatry & neuroscience : JPN| PubMed ID: 25768030

2015
Neurological consequences of traumatic brain injuries in sports.

Molecular and cellular neurosciences| PubMed ID: 25770439

2015
2015
2015
2015
Amyloid biomarkers in Alzheimer's disease.

Trends in pharmacological sciences| PubMed ID: 25840462

2015
2015
2015
2015
2015
2015
2015
2015
2015
Increased levels of inflammatory immune mediators in vitreous from pseudophakic eyes.

Investigative ophthalmology & visual science| PubMed ID: 26024125

2015
CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairment.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology| PubMed ID: 26024928

2015
Benchmarking biomarker-based criteria for Alzheimer's disease: Data from the Swedish Dementia Registry, SveDem.

Alzheimer's & dementia : the journal of the Alzheimer's Association| PubMed ID: 26079415

2015
C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association| PubMed ID: 26092348

2015
2015
2015
Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia.

Brain : a journal of neurology| PubMed ID: 26133663

2015
2015
Pre-analytical and analytical factors influencing Alzheimer's disease cerebrospinal fluid biomarker variability.

Clinica chimica acta; international journal of clinical chemistry| PubMed ID: 26141614

2015
2015
The Gothenburg MCI study: Design and distribution of Alzheimer's disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism| PubMed ID: 26174331

2016
2015
The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans.

Alzheimer's & dementia : the journal of the Alzheimer's Association| PubMed ID: 26194312

2015
Clearance systems in the brain-implications for Alzheimer disease.

Nature reviews. Neurology| PubMed ID: 26195256

2015
Round robin test on quantification of amyloid-β 1-42 in cerebrospinal fluid by mass spectrometry.

Alzheimer's & dementia : the journal of the Alzheimer's Association| PubMed ID: 26206625

2016
Alzheimer's disease--subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism| PubMed ID: 26219595

2016
2015
Plasma amyloid β-quo vadis?

Neurobiology of aging| PubMed ID: 26234755

2015
2015
2015
2015
2015
2015
2015
A Practical Guide to Immunoassay Method Validation.

Frontiers in neurology| PubMed ID: 26347708

2015
2015
Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study.

Alzheimer's & dementia : the journal of the Alzheimer's Association| PubMed ID: 26368321

2016
2015
2015
Biomarkers in Sporadic and Familial Alzheimer's Disease.

Journal of Alzheimer's disease : JAD| PubMed ID: 26401553

2015
2015
2015
2015
2015
2015
2015
2015
2015
2015
2015
2015
2016
2015
2016
2015
CACNA1C polymorphism and altered phosphorylation of tau in bipolar disorder.

The British journal of psychiatry : the journal of mental science| PubMed ID: 26541689

2016
2016
2016
Serum IGF-1 is higher in patients with idiopathic normal pressure hydrocephalus than in the population.

Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society| PubMed ID: 26572963

2015
2016
Cardiorespiratory Fitness Attenuates the Influence of Amyloid on Cognition.

Journal of the International Neuropsychological Society : JINS| PubMed ID: 26581795

2015
2015
2016
2016
2016
2015
2015
Intracranial Arterial 4D-Flow is Associated with Metrics of Brain Health and Alzheimer's Disease.

Alzheimer's & dementia (Amsterdam, Netherlands)| PubMed ID: 26693176

2015
2015
2016
Selective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer's disease.

Journal of neurology, neurosurgery, and psychiatry| PubMed ID: 26746185

2016
2016
2016
Effect of Docosahexaenoic Acid on a Biomarker of Head Trauma in American Football.

Medicine and science in sports and exercise| PubMed ID: 26765633

2016
Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease.

Annals of clinical and translational neurology| PubMed ID: 26783546

2016
2016
2016
2015
2015
2016
2016
Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society| PubMed ID: 26878815

2016
2016
2016
2016
α-Synuclein in Neurodegeneration-A Good Protein that may go Bad.

Brain pathology (Zurich, Switzerland)| PubMed ID: 26940253

2016
2016
2016
2016
2016
2016
Cerebrospinal fluid ratios with Aβ42 predict preclinical brain β-amyloid accumulation.

Alzheimer's & dementia (Amsterdam, Netherlands)| PubMed ID: 26955655

2016
2016
The Vanderbilt Memory & Aging Project: Study Design and Baseline Cohort Overview.

Journal of Alzheimer's disease : JAD| PubMed ID: 26967211

2016
Identification of tissue-specific cell death using methylation patterns of circulating DNA.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 26976580

2016
2016
2016
2016
2016
Clearance systems in the brain--implications for Alzheimer diseaser.

Nature reviews. Neurology| PubMed ID: 27020556

2016
2016
CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease.

Annals of clinical and translational neurology| PubMed ID: 27042676

2016
Plasma neurofilament light chain predicts progression in progressive supranuclear palsy.

Annals of clinical and translational neurology| PubMed ID: 27042681

2016
2016
2016
2016
2016
2016
2016
2016
2016
CSF Aβ1-42 - an excellent but complicated Alzheimer's biomarker - a route to standardisation.

Clinica chimica acta; international journal of clinical chemistry| PubMed ID: 27216941

2016
2015
2015
Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia.

Alzheimer's & dementia (Amsterdam, Netherlands)| PubMed ID: 27239524

2015
2016
2016
Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia.

Movement disorders : official journal of the Movement Disorder Society| PubMed ID: 27296778

2016
2016
APOE ε4 carriers may undergo synaptic damage conferring risk of Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association| PubMed ID: 27321472

2016
2016
2016
2016
2016
2016
2016
2016
2016
2016
2016
2016
2016
2016
2016
Validation of a new assay for α-synuclein detection in cerebrospinal fluid.

Clinical chemistry and laboratory medicine| PubMed ID: 27474841

2016
2016
2016
2016
2016
2016
Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS.

Neurology® neuroimmunology & neuroinflammation| PubMed ID: 27536708

2016
2016
2016
2016
2016
2016
2016
Specific Triazine Herbicides Induce Amyloid-β42 Production.

Journal of Alzheimer's disease : JAD| PubMed ID: 27589520

2016
2016
2016
2016
2016
2016
The ACE Gene Is Associated with Late-Life Major Depression and Age at Dementia Onset in a Population-Based Cohort.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry| PubMed ID: 27639288

2016
2016
2016
2016
2016
2016
2016
2016
Preclinical Amyloid-β and Axonal Degeneration Pathology in Delirium.

Journal of Alzheimer's disease : JAD| PubMed ID: 27662296

2016
2016
2016
2016
Plasma concentrations of free amyloid-β cannot predict the development of Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association| PubMed ID: 27693182

2016
A common challenge in older adults: Classification, overlap, and therapy of depression and dementia.

Alzheimer's & dementia : the journal of the Alzheimer's Association| PubMed ID: 27693188

2016
Plasma tau in Alzheimer disease.

Neurology| PubMed ID: 27694257

2016
2016
2016
Blood Biomarkers for Alzheimer's Disease: Much Promise, Cautious Progress.

Molecular diagnosis & therapy| PubMed ID: 27738910

2017
2017
2016
2016
2017
2017
2017
2017
2017
The immune response of the human brain to abdominal surgery.

Annals of neurology| PubMed ID: 28253549

2017
2017
2017
2017
Applying fluid biomarkers to Alzheimer's disease.

American journal of physiology. Cell physiology| PubMed ID: 28424166

2017
2017
2017
2017
2017
Cerebrospinal fluid monoamine metabolite profiles in bipolar disorder, ADHD, and controls.

Journal of neural transmission (Vienna, Austria : 1996)| PubMed ID: 28656371

2017
2017
2017
2017
Serum tau and neurological outcome in cardiac arrest.

Annals of neurology| PubMed ID: 28981963

2017
2017
2017
2017
2017
Obstructive Sleep Apnea Severity Affects Amyloid Burden in Cognitively Normal Elderly: A Longitudinal Study.

American journal of respiratory and critical care medicine| PubMed ID: 29125327

2017
2017